News
CMND
0.8103
-4.67%
-0.0397
Psychedelic: Optimi completes psilocybin production for Phase 2 trial
TipRanks · 6h ago
SciSparc expands U.S. IP portfolio in collaboration with Clearmind Medicine
TipRanks · 1d ago
Clearmind Medicine announces publication in U.S. of 3 patent applications
TipRanks · 1d ago
Clearmind Medicine Announces Three U.S. Patent Applications Covering Novel Proprietary Combinations Of LSD, Ketamine And Ibogaine With N-Acylethanolamines Such As Palmitoylethanolamide
Benzinga · 1d ago
Clearmind Enhances U.S. IP Presence with Publication of Three Patent Applications Covering LSD, Ketamine and Ibogaine Combinations
Barchart · 1d ago
Weekly Report: what happened at CMND last week (0914-0918)?
Weekly Report · 3d ago
Biotech Stocks In Focus: Aethlon, Tiziana, Capricor, Firefly & Clearmind
NASDAQ · 09/17 18:28
Clearmind Medicine Briefs FDA On Patient Access At Psychedelic Hearing
NASDAQ · 09/17 13:58
Psychedelic: Definium’s LSD-based drug meets endpoints in GAD study
TipRanks · 09/17 13:55
Morning Movers: Yeti gains after issuing guidance at investor day
TipRanks · 09/17 13:06
Clearmind Medicine briefs FDA following psychedelic hearing in Washington D.C.
TipRanks · 09/17 11:50
Clearmind Medicine Delivers Briefing to FDA Following Invitation to Historic Psychedelic Hearing in Washington, D.C.
Barchart · 09/17 06:42
Weekly Report: what happened at CMND last week (0907-0911)?
Weekly Report · 09/14 09:33
Clearmind Medicine enrolls first patients with AUD in CMND-100 trial
TipRanks · 09/11 12:20
Clearmind Medicine Inc. GAAP EPS of -$0.57
Seeking Alpha · 09/10 20:19
Psychedelic: Optimi to initiate Phase 2 trial of psilocybin-assisted therapy
TipRanks · 09/10 14:50
Clearmind Medicine announces Yale IRB approval of Parts B, C of CMND-100 trial
TipRanks · 09/08 12:00
Clearmind Medicine Receives Yale IRB Approval For CMND-100 Trial
NASDAQ · 09/08 11:52
Clearmind Medicine Says Yale University’s IRB Approves Initiation Of Patient Recruitment For Parts B And C Of Phase I/II Clinical Trial Evaluating CMND‑100
Benzinga · 09/08 11:43
Weekly Report: what happened at CMND last week (0831-0904)?
Weekly Report · 09/07 09:31
More
Webull provides a variety of real-time CMND stock news. You can receive the latest news about Clearmind Medici through multiple platforms. This information may help you make smarter investment decisions.
About CMND
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.